Price
CHART BY
Frequently asked questions
What is BICO Group's market capitalization?
What is the Earnings Per Share (EPS) for BICO Group?
What are the analyst ratings and target price for BICO Group's stock?
What is BICO Group's revenue over the trailing twelve months?
What is the EBITDA for BICO Group?
What is the free cash flow of BICO Group?
What is the free float of BICO Group's shares?
Financials
- Market Cap
- $178.90M
- EPS (TTM)
- -$0.475
- Free Float
- 43.16M
- Revenue (TTM)
- $187.91M
- EBITDA (TTM)
- $6.57M
- Free Cashflow (TTM)
- $26.31M
Pricing
- 1D span
- $2.461$2.574
- 52W span
- $2.483$5.556
Analyst Ratings
The price target is $3.908 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Life Science Solutions, Lab Automation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Life Science Solutions segment supplies advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Lab Automation segment offers proprietary and hardware-agnostic Green Button Go Suite software for connected and smart workflows. The Group segment is involved in the group’s administration and shareholder costs. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in March 2015 and is headquartered in Gothenburg, Sweden.
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- SE0013647385
- Primary Ticker
- BICO